$230MStrategic acquisitionHealthcare & Life SciencesCompleted
Astromech buys Form Bio in $230M all-stock deal
Astromech, an AI company building predictive models of biological change, acquired Dallas-based Form Bio in an all-stock deal valued at $230 million. It brings over Form Bio's IP, selected contracts, assets and team; co-founder Andrew Busey becomes Astromech's Chief AI Officer.
Why it matters: The deal pairs evolutionary AI modeling with tools for designing manufacturable genetic medicines.
Read the full coverage, free
We only link to sources you can read without a subscription. How we check.
Following healthcare M&A?
The next big healthcare deal will be in our email the morning after it's announced, with the rest of the day's biggest deals. Free, with no paywalled links.
See what you get →